Famotack®

Famotidine
H2 Receptor Blocker (Antiulcerant)

Famotidine USP,Antiulcerants

Indication:

Duodenal ulcer, Gastric ulcer, Gastro-esophageal reflux disease and Zollinger-Ellison syndrome, Gastritis.

Dosage & Administration:

Tablet:
20 mg twice daily. Maintenance therapy as Famotack^® 20 one tablet at night.

Powder for Suspension:

Gastroesophageal Reflux Disease (GERD):
< 1 year of age: 0.5 mg/kg/dose of famotidine oral suspension up to 8 weeks once daily in patients
Age 3 to 11 months: 0.5 mg/kg/dose twice daily up to 8 weeks
Age 1 to 2 months: 0.5 mg/kg/dose once daily up to 8 weeks
Neonates: 0.5 mg/kg/dose maximum once daily up to 8 weeks

Patients 1-16 years of age:
Gastroesophageal Reflux Disease (GERD):1.0 mg/kg/day p.o. divided b.i.d. up to 40 mg b.i.d.
Duodonal ulcer: 0.5 mg/kg/day p.o. at bedtime or divided b.i.d. up to 40 mg/day.
Peptic ulcer: 0.5 mg/kg/day p.o. at bedtime or divided b.i.d. up to 40 mg/day.
Maintenance therapy: 40 mg at daily night.
Reflux esophagitis: 2 mg/kg/day
Zollinger- Ellison Syndrome: 40 mg 3 times daily.

Preparation:

Famotack^® 20 tablet : Box containing 10 x 10 tablets in blister pack.
Famotack^® 40 tablet : Box containing 5 x 10 tablets in blister pack.
Famotack Powder for suspension: Box containing sealed cap HDPE bottle containg dry powder for reconstituting 50 ml suspension with a dropper.